US Stock MarketDetailed Quotes

SERNOVA BIOTHERAPEUTICS INC (SEOVF)

Watchlist
  • 0.1287
  • -0.0013-1.00%
15min DelayClose Apr 24 15:22 ET
44.75MMarket Cap-4.44P/E (TTM)

SERNOVA BIOTHERAPEUTICS INC (SEOVF) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Jan 31, 2026
(FY)Oct 31, 2025
(Q4)Oct 31, 2025
(Q3)Jul 31, 2025
(Q2)Apr 30, 2025
(Q1)Jan 31, 2025
(FY)Oct 31, 2024
(Q4)Oct 31, 2024
(Q3)Jul 31, 2024
(Q2)Apr 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
78.31%-1.05M
42.27%-10.91M
95.64%-171.13K
40.54%-2.07M
46.99%-3.84M
-13.62%-4.83M
37.72%-18.9M
65.43%-3.92M
22.13%-3.48M
19.94%-7.24M
Net income from continuing operations
59.01%-2.33M
51.10%-15.74M
55.77%-2.2M
45.95%-4.07M
62.01%-3.78M
41.55%-5.7M
17.45%-32.19M
57.55%-4.97M
24.11%-7.54M
-6.38%-9.94M
Operating gains losses
----
----
----
----
----
----
----
----
--0
----
Depreciation and amortization
-90.70%4.43K
-36.59%342.59K
-63.50%62.22K
13.68%185.05K
-53.63%47.66K
-54.28%47.66K
21.26%540.28K
41.65%170.45K
48.56%162.79K
-5.40%102.79K
Deferred tax
----
---70K
----
----
----
----
--0
----
----
----
Other non cash items
1,441.73%217.03K
448.03%523.74K
259.00%322.14K
-40.30%154.88K
-53.19%62.89K
95.27%-16.18K
77.75%-150.48K
28.81%-202.6K
35.61%259.44K
205.05%134.37K
Change In working capital
484.63%662.33K
-84.44%1.74M
-32.54%982.42K
-56.78%1.36M
-137.75%-715.78K
-97.57%113.29K
123.84%11.16M
436.03%1.46M
-23.14%3.14M
408.32%1.9M
-Change in receivables
96.07%-2.95K
-68.77%175.47K
-46.42%143.42K
-60.42%166.93K
87.69%-59.69K
-121.05%-75.18K
144.60%561.85K
261.94%267.67K
1,262.55%421.75K
-379.26%-484.76K
-Change in prepaid assets
118.63%61.15K
339.70%24.16K
-97.27%15.07K
910.12%330.35K
104.10%6.97K
2.13%-328.24K
64.10%5.49K
1,388.19%551.82K
-170.33%-40.78K
-337.79%-170.15K
-Change in payables and accrued expense
16.92%604.13K
-85.49%1.54M
29.37%823.93K
-68.84%859.06K
-125.99%-663.05K
-88.88%516.71K
122.88%10.59M
308.68%636.87K
-32.11%2.76M
535.77%2.55M
Cash from discontinued investing activities
Operating cash flow
78.31%-1.05M
42.27%-10.91M
95.64%-171.13K
40.54%-2.07M
46.99%-3.84M
-13.62%-4.83M
37.72%-18.9M
65.43%-3.92M
22.13%-3.48M
19.94%-7.24M
Investing cash flow
Cash flow from continuing investing activities
-99.78%24.96K
20.17K
-99.91%4.78K
0
0
-68.03%11.12M
0
-47.58%5.04M
547.80%4M
Net PPE purchase and sale
----
--24.96K
--20.17K
----
----
----
--0
--0
--0
----
Net investment purchase and sale
----
--0
--0
--0
--0
--0
-68.26%11.08M
--0
-47.82%5.04M
556.86%4M
Net other investing changes
----
----
----
----
----
----
200.00%35.3K
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
--0
-99.78%24.96K
--20.17K
-99.91%4.78K
--0
--0
-68.03%11.12M
--0
-47.58%5.04M
547.80%4M
Financing cash flow
Cash flow from continuing financing activities
5,969.74%1.36M
1.35%5.14M
-93.24%332.34K
482.22%153.44K
2,675.03%4.63M
151.87%22.38K
906.52%5.07M
4,037.51%4.92M
161.52%26.35K
36.26%166.76K
Net issuance payments of debt
--0
2,949.54%4.82M
299.14%83.7K
465.07%153.44K
11,110.20%4.63M
1.60%-42.45K
1.57%-169.23K
3.18%-42.03K
1.89%-42.03K
1.89%-42.03K
Net common stock issuance
--1.36M
-94.99%248.64K
----
----
----
--0
--4.96M
----
----
----
Proceeds from stock option exercised by employees
----
--0
--0
--0
----
----
--15.75K
--0
--0
----
Net other financing activities
----
-75.20%64.83K
--0
--0
--0
--64.83K
-61.29%261.42K
--0
--68.38K
----
Cash from discontinued financing activities
Financing cash flow
5,969.74%1.36M
1.35%5.14M
-93.24%332.34K
482.22%153.44K
2,675.03%4.63M
151.87%22.38K
906.52%5.07M
4,037.51%4.92M
161.52%26.35K
36.26%166.76K
Net cash flow
Beginning cash position
-95.59%265K
-31.07%6.01M
-98.33%83.62K
-41.89%2M
-81.45%1.21M
-31.07%6.01M
130.98%8.72M
-71.77%5.02M
-72.89%3.44M
-71.06%6.51M
Current changes in cash
106.48%311.22K
-112.11%-5.75M
-81.73%181.39K
-221.04%-1.91M
125.72%790.14K
-117.18%-4.8M
-154.79%-2.71M
110.97%993.07K
-68.97%1.58M
68.70%-3.07M
End cash Position
-52.28%576.22K
-95.59%265K
-95.59%265K
-98.33%83.62K
-41.89%2M
-81.45%1.21M
-31.07%6.01M
-31.07%6.01M
-71.77%5.02M
-72.89%3.44M
Free cash flow
78.31%-1.05M
42.27%-10.91M
95.64%-171.13K
40.54%-2.07M
46.99%-3.84M
-13.62%-4.83M
37.92%-18.9M
65.43%-3.92M
22.30%-3.48M
20.10%-7.24M
Currency Unit
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
CAD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Jan 31, 2026(FY)Oct 31, 2025(Q4)Oct 31, 2025(Q3)Jul 31, 2025(Q2)Apr 30, 2025(Q1)Jan 31, 2025(FY)Oct 31, 2024(Q4)Oct 31, 2024(Q3)Jul 31, 2024(Q2)Apr 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 78.31%-1.05M42.27%-10.91M95.64%-171.13K40.54%-2.07M46.99%-3.84M-13.62%-4.83M37.72%-18.9M65.43%-3.92M22.13%-3.48M19.94%-7.24M
Net income from continuing operations 59.01%-2.33M51.10%-15.74M55.77%-2.2M45.95%-4.07M62.01%-3.78M41.55%-5.7M17.45%-32.19M57.55%-4.97M24.11%-7.54M-6.38%-9.94M
Operating gains losses ----------------------------------0----
Depreciation and amortization -90.70%4.43K-36.59%342.59K-63.50%62.22K13.68%185.05K-53.63%47.66K-54.28%47.66K21.26%540.28K41.65%170.45K48.56%162.79K-5.40%102.79K
Deferred tax -------70K------------------0------------
Other non cash items 1,441.73%217.03K448.03%523.74K259.00%322.14K-40.30%154.88K-53.19%62.89K95.27%-16.18K77.75%-150.48K28.81%-202.6K35.61%259.44K205.05%134.37K
Change In working capital 484.63%662.33K-84.44%1.74M-32.54%982.42K-56.78%1.36M-137.75%-715.78K-97.57%113.29K123.84%11.16M436.03%1.46M-23.14%3.14M408.32%1.9M
-Change in receivables 96.07%-2.95K-68.77%175.47K-46.42%143.42K-60.42%166.93K87.69%-59.69K-121.05%-75.18K144.60%561.85K261.94%267.67K1,262.55%421.75K-379.26%-484.76K
-Change in prepaid assets 118.63%61.15K339.70%24.16K-97.27%15.07K910.12%330.35K104.10%6.97K2.13%-328.24K64.10%5.49K1,388.19%551.82K-170.33%-40.78K-337.79%-170.15K
-Change in payables and accrued expense 16.92%604.13K-85.49%1.54M29.37%823.93K-68.84%859.06K-125.99%-663.05K-88.88%516.71K122.88%10.59M308.68%636.87K-32.11%2.76M535.77%2.55M
Cash from discontinued investing activities
Operating cash flow 78.31%-1.05M42.27%-10.91M95.64%-171.13K40.54%-2.07M46.99%-3.84M-13.62%-4.83M37.72%-18.9M65.43%-3.92M22.13%-3.48M19.94%-7.24M
Investing cash flow
Cash flow from continuing investing activities -99.78%24.96K20.17K-99.91%4.78K00-68.03%11.12M0-47.58%5.04M547.80%4M
Net PPE purchase and sale ------24.96K--20.17K--------------0--0--0----
Net investment purchase and sale ------0--0--0--0--0-68.26%11.08M--0-47.82%5.04M556.86%4M
Net other investing changes ------------------------200.00%35.3K--0--0--0
Cash from discontinued investing activities
Investing cash flow --0-99.78%24.96K--20.17K-99.91%4.78K--0--0-68.03%11.12M--0-47.58%5.04M547.80%4M
Financing cash flow
Cash flow from continuing financing activities 5,969.74%1.36M1.35%5.14M-93.24%332.34K482.22%153.44K2,675.03%4.63M151.87%22.38K906.52%5.07M4,037.51%4.92M161.52%26.35K36.26%166.76K
Net issuance payments of debt --02,949.54%4.82M299.14%83.7K465.07%153.44K11,110.20%4.63M1.60%-42.45K1.57%-169.23K3.18%-42.03K1.89%-42.03K1.89%-42.03K
Net common stock issuance --1.36M-94.99%248.64K--------------0--4.96M------------
Proceeds from stock option exercised by employees ------0--0--0----------15.75K--0--0----
Net other financing activities -----75.20%64.83K--0--0--0--64.83K-61.29%261.42K--0--68.38K----
Cash from discontinued financing activities
Financing cash flow 5,969.74%1.36M1.35%5.14M-93.24%332.34K482.22%153.44K2,675.03%4.63M151.87%22.38K906.52%5.07M4,037.51%4.92M161.52%26.35K36.26%166.76K
Net cash flow
Beginning cash position -95.59%265K-31.07%6.01M-98.33%83.62K-41.89%2M-81.45%1.21M-31.07%6.01M130.98%8.72M-71.77%5.02M-72.89%3.44M-71.06%6.51M
Current changes in cash 106.48%311.22K-112.11%-5.75M-81.73%181.39K-221.04%-1.91M125.72%790.14K-117.18%-4.8M-154.79%-2.71M110.97%993.07K-68.97%1.58M68.70%-3.07M
End cash Position -52.28%576.22K-95.59%265K-95.59%265K-98.33%83.62K-41.89%2M-81.45%1.21M-31.07%6.01M-31.07%6.01M-71.77%5.02M-72.89%3.44M
Free cash flow 78.31%-1.05M42.27%-10.91M95.64%-171.13K40.54%-2.07M46.99%-3.84M-13.62%-4.83M37.92%-18.9M65.43%-3.92M22.30%-3.48M20.10%-7.24M
Currency Unit CADCADCADCADCADCADCADCADCADCAD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More